Baim 2000 |
ProStar‐Plus device was used with an 8 Fr or 10 Fr sheath size, but data are not presented separately. We contacted study authors twice but received no response |
Beyer‐Enke 1996 |
Could not confirm with study authors that access for the procedure was attained through the femoral artery |
Chalmers 2007 |
EVICEL is not a vascular closure device |
Chevalier 2000 |
Data on review outcomes were not presented in the study report (abstract) |
Jean‐Baptiste 2008 |
Not a randomised controlled trial |
Kurşaklioĝlu 2008 |
Cannot confirm that this is a randomised controlled trial and that access was attained via the femoral artery |
Larzon 2015 |
Did not use a vascular closure device |
Leinbudgut 2013 |
Participants were randomised by drug received to prevent bleeding rather than by vascular closure device (VCD) |
Lupi 2012 |
Not a randomised controlled trial |
Neudecker 2003 |
Not a randomised controlled trial |
Ratnam 2007 |
Not a randomised controlled trial |
Slaughter 1995 |
Cost‐effectiveness analysis. No relevant data |
Smilowitz 2012 |
Not a randomised controlled trial |
Starnes 2003 |
Arteriography participants who were treated with 7 Fr to 10 Fr sheaths. Data are not presented according to sheath size. Attempts to contact the study author for specific data were unsuccessful |